NDA 204071 describes SODIUM POLYSTYRENE SULFONATE, which is a drug marketed by
Belcher,
Chartwell Rx,
Citrusphrma,
Cmp Pharma Inc,
Epic Pharma Llc,
Nuvo Pharms Inc,
Pai Holdings Pharm,
Upsher Smith Labs,
Ani Pharms,
Hikma,
Morton Grove, and
Roxane, and is included in twelve NDAs. It is available from
nine suppliers. Additional details are available on the
SODIUM POLYSTYRENE SULFONATE profile page.
The generic ingredient in SODIUM POLYSTYRENE SULFONATE is
sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two
drug master file entries for this compound. Twelve
suppliers are listed for this compound. Additional details are available on the
sodium polystyrene sulfonate profile page.